## ISRG: Intuitive Surgical, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -1.9% below STRENGTH zone (3.0-6.0%); PEG 3.55 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($543.07)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 0)

**1. Intuitive Surgical (ISRG): Revisiting Valuation After a 25% Three-Month Share Price Rally**
- Source: Simply Wall Street | 20251204T085944 | Somewhat-Bullish | Relevance: 100%
- Intuitive Surgical (ISRG) has seen its share price rally by about 25% over the past three months, prompting a re-evaluation of its valuation. While a fair value narrative suggests it's 3.9% undervalued at $592.96 due to innovation and growth prospects, other metrics show it trading at a significantly higher PE ratio than its industry and peers. Investors need to weigh the strong growth story against potential valuation risks and intense competition.

**2. Intuitive Surgical (ISRG) Declined Due to Managementâ€™s Cautious Commentary**
- Source: Yahoo! Finance Canada | 20251203T135200 | Somewhat-Bearish | Relevance: 100%
- Intuitive Surgical (ISRG) stock declined despite strong second-quarter results and raised full-year procedure guidance. The decline is attributed to management's cautious commentary on the European capital expenditure environment and conservative forward margin guidance, impacting investor sentiment. Brown Advisory's Large-Cap Growth Strategy noted this in its Q3 2025 investor letter, while also mentioning the strategic choice to underweight highly speculative AI stocks.

**3. OMERS ADMINISTRATION Corp Has $7.95 Million Holdings in Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251202T020926 | Somewhat-Bullish | Relevance: 100%
- OMERS ADMINISTRATION Corp decreased its stake in Intuitive Surgical, Inc. to 14,637 shares valued at $7.95 million after selling 5,368 shares in Q2. Despite this, Intuitive Surgical outperformed quarterly expectations with $2.40 EPS and $2.51 billion in revenue, reflecting a 22.9% year-over-year increase. However, recent insider selling, including EVP Henry L. Charlton's sale of 13,731 shares for $7.96 million, indicates a total of $48.0 million in insider sales over the last three months.

**4. Chmn Guthart Files To Sell 22,806 Of Intuitive Surgical Inc [ISRG]**
- Source: TradingView | 20251202T020821 | Somewhat-Bearish | Relevance: 100%
- Gary S. Guthart, Chairman of the Board of Intuitive Surgical Inc [ISRG], filed a Form 144 on December 1, 2025, proposing to sell 22,806 restricted shares. The sale is planned for approximately December 1, 2025, through Morgan Stanley Smith Barney LLC, pursuant to a prearranged trading plan (10b5-1). This filing allows the sale of restricted shares within 90 days of submission to the SEC.

**5. Intuitive Surgical, Inc. (ISRG): A Bull Case Theory**
- Source: Insider Monkey | 20251204T114200 | Somewhat-Bullish | Relevance: 100%
- This article summarizes a bullish thesis on Intuitive Surgical, Inc. (ISRG), highlighting its dominance in robotic-assisted surgery with the da Vinci system and a robust, high-margin business model. Despite competition and a rich valuation, the company's strong financial performance, recurring revenue, and long-term growth potential in minimally invasive surgery make it an attractive investment, particularly at lower entry points.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 5 ($2.98M) |
| Sells | 13 ($5.48M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.6% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.4% (+0.8%)
- Blackrock Inc.: 8.8% (+0.1%)
- State Street Corpora: 4.3% (-0.1%)
- Price (T.Rowe) Assoc: 3.6% (-4.4%)
- Geode Capital Manage: 2.3% (+1.0%)

### Key Risks

1. Insider selling cluster: $5.5M in recent transactions.
2. Valuation stretched: PEG 3.5x requires aggressive growth execution.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.55 signals overvaluation risk, limited margin of safety. Forward P/E 58.3x stretched relative to 13% growth. Quality metrics strong (margin 29%). Balance sheet: strong liquidity (4.7x), low leverage (D/E 0.14). Institutional flow bearish (4 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $207.1B |
| Beta | 1.69 |
| 52W Range | $425.00 - $616.00 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.55 |
| Forward P/E | 58.3 |
| Current P/E | 65.8 |
| YoY Growth | 12.8% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from -0.6% to -1.9% (-1.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.9pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-2.78), momentum weakening. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.90% (CS: 33) | Neutral |
| RSI_14 | 60.6 | Neutral |
| MACD Histogram | -2.78 | Bearish |
| vs SMA20 | 1.008x | Above |
| vs SMA50 | 1.108x | Above |
| vs SMA200 | 1.117x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $568.63
- **Stop Loss:** $543.07 (4.5% risk)
- **Target:** $594.19 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 19
- **Position Value:** $10,803.97
- **Portfolio %:** 10.80%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-01-22 (Est: $2.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.99 | $2.40 | +20.7% |
| 2025Q2 | $1.92 | $2.19 | +14.1% |
| 2025Q1 | $1.73 | $1.81 | +4.4% |
| 2024Q4 | $1.79 | $2.21 | +23.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*